The primary focus of this document is to provide a consistent guidance for pharmaceutical companies to calculate GHG emissions in their upstream and downstream value chains. It provides methodologies consistent with recommendations from the GHG Protocol for calculating emissions which are tailored for each different category.

This document was developed by the Pharmaceutical Environment Group (PEG) and its participating companies, who have kindly shared it with the PSCI for diffusion.